Feb 25, 2019

Where Medicare Advantage is most popular

Expand chart
Data: Centers for Medicare & Medicaid Services; Map: Harry Stevens/Axios

States in the Midwest, South and West have the highest proportions of Medicare members enrolled in Medicare Advantage. Some states have more than 40% of their Medicare population in the taxpayer-subsidized private plans.

The big picture: Roughly a third of all Medicare enrollees are in MA, a program that has garnered bipartisan support despite its shortcomings, and some Wall Street estimates think MA will be the majority option by 2021.

By the numbers: More than 22 million seniors and people with disabilities have a Medicare Advantage plan, according to February 2019 enrollment data from the Centers for Medicare & Medicaid Services. The map highlights enrollment data from 2017, when there were 19.2 million MA enrollees.

  • The state with the highest proportion of private Medicare plan enrollees (57.3%) is Minnesota, although many people are enrolled in "Medicare cost" plans that function as a hybrid between MA and traditional Medicare.
  • MA is the choice of at least 40% of all Medicare enrollees in 6 other states (California, Florida, Hawaii, Oregon, Pennsylvania and Rhode Island).
  • MA is far less popular in states with sparse populations, like Alaska, Vermont and Wyoming.

Between the lines: States with high concentrations of MA enrollees also have dominant systems of hospitals and doctors that sell MA plans.

  • Many MA members in Pennsylvania buy plans from Highmark, Geisinger and UPMC, while Kaiser Permanente has a strong grip of the market along the West Coast.

What to watch: Health insurance companies will always aggressively pursue areas where there are a lot of seniors, like Florida and California, but the distribution shows there are pockets of the Midwest and Northeast that could be their next targets.

Go deeper

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 3 a.m. ET: 665,164 — Total deaths: 30,852 — Total recoveries: 140,225.
  2. U.S.: Leads the world in cases. Total confirmed cases as of 3 a.m. ET: 124,665 — Total deaths: 2,191 — Total recoveries: 1,095.
  3. Federal government latest: President Trump announces new travel advisories for New York, New Jersey and Connecticut, but rules out quarantine enforcement. Per the CDC, residents of those states must now "refrain from non-essential domestic travel for 14 days," with the exception of critical infrastructure industry workers.
  4. State updates: Alaska is latest state to issue a stay-at-home order — New York is trying to nearly triple its hospital capacity in less than a month and has moved its presidential primary to June 23. Some Midwestern swing voters who backed Trump's handling of the virus less than two weeks ago are balking at his call for the U.S. to be "opened up" by Easter.
  5. World updates: In Spain, over 1,400 people were confirmed dead between Thursday to Saturday.
  6. 🚀 Space updates: OneWeb filed for bankruptcy amid the novel coronavirus pandemic.
  7. Hollywood: Tom Hanks and Rita Wilson have returned to U.S. after being treated for coronavirus.
  8. What should I do? Answers about the virus from Axios expertsWhat to know about social distancingQ&A: Minimizing your coronavirus risk
  9. Other resources: CDC on how to avoid the virus, what to do if you get it.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Coronavirus updates: Global death toll tops 30,000

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens and confirmed plus presumptive cases from the CDC

The novel coronavirus has now killed more than 30,000 people around the world — with Italy reporting over 10,000 deaths, per Johns Hopkins data.

The big picture: The number of deaths from COVID-19 in the U.S. surpassed 2,000 on Saturday. The United States leads the world in confirmed coronavirus infections — more than 124,000 by early Sunday. The number of those recovered from the virus in the U.S. passed the 1,000-mark on Saturday evening.

Go deeperArrowUpdated 2 hours ago - Health

Gilead expands access to experimental coronavirus drug in emergency cases

Photo: Olivier Douliery/AFP via Getty Images

Gilead Sciences CEO Daniel O’Day said in an open letter Saturday the company is expanding access to its experimental anti-coronavirus drug remdesivir to include severely ill COVID-19 patients.

The big pig picture: President Trump has called the antiviral drug "promising," but the results of six clinical trials on this investigational medicine are still being conducted, so its effectiveness the treatment of the novel coronavirus has yet to be proved. The World Health Organization is involved in the tests.

Go deeperArrow3 hours ago - Health